ArticleJournal of veterinary science2025
Effect of ELHLD peptide for stifle function recovery after tibial plateau leveling osteotomy in dogs.
Article in Journal of veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importancePatients with arthritis and ruptured cruciate ligaments typically require surgery. Following surgery, it is necessary to improve joint function in early stage.
objectiveThis study aimed to investigate the impact of intraoperative intra-articular injection of the ELHLD peptide (L-glutamyl-L-leucyl-L-histidyl-L-leucyl-L-aspartic acid) on postoperative stifle function in patients with medial patella luxation grade 3 and osteoarthritis grade 2 undergoing tibial plateau leveling osteotomy due to anterior cruciate ligament (ACL) rupture.
methodsA total of 12 dogs participated, with 6 dogs assigned to the control group and 6 to the ELHLD peptide treatment group. The ELHLD peptide was administered by intra-articular injection to patients, and the following aspects were compared with the control: hindlimb circumference, balance evaluation score (BES), muscle mass, and stifle function score (SFS). These assessments were conducted at 2, 4, 8, and 12 weeks after surgery.
resultsIn the treatment group, hindlimb circumference suggested an effect on the recovery stifle function at the 4th and 8th week ( CONCLUSIONS AND RELEVANCE: The use of ELHLD injections is meaningful in that it helps rapid recovery of joint function in the early stages after surgery. This research might improve the satisfaction of the caregiver, and facilitate the overall recovery process in the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.